Additionally, miR210 was detected in serum sEVs of HCC patients, and it induced angiogenesis in vitro by targeting SMAD4, the signal transducer, and the activator of transcription 6 (STAT6) signaling, emphasizing the important role of angiogenesis in HCC dissemination [105]. Here, SMAD4 is linked to hepatocellular carcinoma.